Jefferies Financial Group Inc. raised its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 212.7% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 335,820 shares of the company’s stock after acquiring an additional 228,424 shares during the quarter. Jefferies Financial Group Inc.’s holdings in GE HealthCare Technologies were worth $27,544,000 at the end of the most recent quarter.
Several other large investors have also bought and sold shares of the company. Western Wealth Management LLC boosted its position in GE HealthCare Technologies by 2.4% during the 4th quarter. Western Wealth Management LLC now owns 5,240 shares of the company’s stock valued at $430,000 after acquiring an additional 125 shares in the last quarter. United Community Bank boosted its position in GE HealthCare Technologies by 10.2% during the 4th quarter. United Community Bank now owns 1,410 shares of the company’s stock valued at $116,000 after acquiring an additional 130 shares in the last quarter. Thoma Capital Management LLC boosted its position in GE HealthCare Technologies by 1.4% during the 4th quarter. Thoma Capital Management LLC now owns 9,918 shares of the company’s stock valued at $814,000 after acquiring an additional 136 shares in the last quarter. Colonial Trust Advisors boosted its position in GE HealthCare Technologies by 11.1% during the 3rd quarter. Colonial Trust Advisors now owns 1,391 shares of the company’s stock valued at $104,000 after acquiring an additional 139 shares in the last quarter. Finally, Norinchukin Bank The boosted its position in GE HealthCare Technologies by 0.4% during the 3rd quarter. Norinchukin Bank The now owns 38,913 shares of the company’s stock valued at $2,922,000 after acquiring an additional 149 shares in the last quarter. 82.06% of the stock is owned by institutional investors.
Insider Activity
In other GE HealthCare Technologies news, Director Watkin Phoebe L. Yang bought 1,000 shares of the stock in a transaction dated Friday, May 8th. The stock was purchased at an average cost of $63.01 per share, for a total transaction of $63,010.00. Following the completion of the acquisition, the director owned 13,702 shares of the company’s stock, valued at approximately $863,363.02. This trade represents a 7.87% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Frank R. Jimenez acquired 1,750 shares of the firm’s stock in a transaction that occurred on Thursday, April 30th. The stock was purchased at an average price of $60.45 per share, with a total value of $105,787.50. Following the completion of the acquisition, the insider owned 93,932 shares in the company, valued at $5,678,189.40. The trade was a 1.90% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last ninety days, insiders bought 11,847 shares of company stock valued at $719,555. 0.36% of the stock is currently owned by insiders.
Analysts Set New Price Targets
Check Out Our Latest Analysis on GEHC
GE HealthCare Technologies Price Performance
GEHC stock opened at $64.23 on Friday. The firm has a 50 day moving average price of $68.45 and a 200-day moving average price of $76.24. GE HealthCare Technologies Inc. has a 52-week low of $58.75 and a 52-week high of $89.77. The firm has a market capitalization of $29.22 billion, a price-to-earnings ratio of 15.37, a PEG ratio of 1.45 and a beta of 0.74. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last released its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.04 billion. During the same quarter in the previous year, the business posted $1.01 earnings per share. GE HealthCare Technologies’s revenue for the quarter was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.89 EPS for the current fiscal year.
GE HealthCare Technologies Profile
GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.
In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.
Read More
- Five stocks we like better than GE HealthCare Technologies
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
